2019 American Transplant Congress
The Need for Diabetic Medications after Pancreas Transplantation
Mount Sinai Hospital, New York, NY
*Purpose: Patients with diabetes mellitus can experience microvascular complications resulting in end organ damage ultimately necessitating pancreatic transplantation. While there is well documented improvement in…2018 American Transplant Congress
Pancreas Transplant Recipients with End-Stage Renal Disease Benefit from Kidney Transplantation
Background: End-stage renal disease (ESRD) has been shown after pancreas transplant alone (PTA), however, the benefit of kidney transplantation (KT) in PTA recipients with ESRD…2018 American Transplant Congress
Pancreas Outcomes between Living and Deceased Kidney Donor Recipients in Pancreas after Kidney Transplantation
Pancreas outcomes in pancreas after kidney transplantation have been reported as being inferior to those from simultaneous pancreas-pancreas (SPK). The influence of kidney donor (living-…2018 American Transplant Congress
Analysis of NIH Research Funding in Transplantation: The Important Impact of Physician-Scientists in Abdominal Transplant Research
Surgery, University of Virginia, Charlottesville, VA.
Introduction: Obtaining National Institutes of Health (NIH) funding for scientific research has become increasingly difficult. With increasing clinical demands and declining NIH funding, performing research…2018 American Transplant Congress
Morphometric and Metabolic Correlates of Frailty in Pancreas Transplant Recipients
Surgery, Emory University, Atlanta, GA.
Background: Prediction of survival and health resource utilization in the pancreas transplant population requires novel approaches to risk stratification. We studied whether sarcopenia and osteopenia,…2018 American Transplant Congress
Pancreas Retransplantation: Outcomes of This Technical and Immunological Challenge over 38 Patients
IntroductionPancreas transplantation is now a mastered technique for patients suffering from severe diabetes. However, a significant number of grafts are lost for technical and immunological…2018 American Transplant Congress
Maximizing Utilization in Pancreas Transplantation: Phenotypic CharacteristicsDifferentiating Aggressive from Nonaggressive Transplant Centers
OBJECTIVE: Given the increasing shortage of deceased donor pancreas allografts and their declining acceptance rate, maximizing utilization requires a balance between donor selection and transplant…2018 American Transplant Congress
Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients
University of Wisconsin School of Medicine and Public Health, Madison, WI.
Background: Development of de novo donor-specific antibodies (dnDSA) has detrimental effects on kidney graft survival. But, there is limited information about the relationship of dnDSA…2018 American Transplant Congress
A Study to Identify Marginal Factors for Donors of Pancreas Transplantation in Japan
ObjectiveAlthough pancreas transplantation is generally performed with donors in less-than-ideal condition in Japan, such as over 40% of donors being over 45 years of age…2018 American Transplant Congress
Enteric Conversion after Bladder-Drained Pancreas Transplantation: The Wisconsin Experience
Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI.
INTRODUCTION: In the early experience of pancreas transplantation, bladder drainage was favored. However, this often caused metabolic and infectious complications that necessitated conversion to enteric…
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 28
- Next Page »